Endocrine Testing Market - Global Industry Analysis
Endocrine Testing Market By Tests (Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH),Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), Testosterone, Thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and Other Test), By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Sensors, Clinical Chemistry Technologies, and Others), By End-user (Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals, and Other Healthcare Settings): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028
Published Date: 08-Jun-2021Medical Device
Category: Report Format : PDF
Report Code: ZMR-385
Status : Published
The global Endocrine Testing market accounted for USD 8.4 Billion in 2020 and is expected to reach USD 16.6 Billion by 2028, growing at a CAGR of 8.9% from 2021 to 2028.